未登录

J

Jayanth Doss

Duke University

H指数:9

被引数:330

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus

系统性红斑狼疮患者血清中自身抗体与补体水平的关系

Clinical Immunology

IF3.8

2026-09-250

PRE

Racial differences in medication beliefs and adherence barriers among patients with systemic lupus erythematosus

系统性红斑狼疮患者中种族差异对药物信念和依从性障碍的影响

IF1.9

2025-12-010

PRE

Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus

JOURNAL OF RHEUMATOLOGY

IF3.4

2024-06-011

PRE

Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Score for You

JOURNAL OF RHEUMATOLOGY

IF3.4

2024-05-151

PRE

Interpreting hydroxychloroquine blood levels for medication non-adherence: a pharmacokinetic study

LUPUS SCIENCE & MEDICINE

IF3.5

2024-04-302

OAAI

Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms

2型系统性红斑狼疮症状的医师整体评估的开发和心理评估

LUPUS SCIENCE & MEDICINE

IF3.5

2023-12-172

OAAI

Encounter Appropriateness Score for You Model: Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth in Rheumatology

ARTHRITIS CARE & RESEARCH

IF3.3

2023-11-136

PRE

Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence (vol 50, 220399, 2022)

JOURNAL OF RHEUMATOLOGY

IF3.4

2023-02-010

OA

Association of Hurried Communication and Low Patient Self-Efficacy With Persistent Nonadherence to Lupus Medications

ARTHRITIS CARE & RESEARCH

IF3.3

2022-11-153

OA

Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data

ARTHRITIS CARE & RESEARCH

IF3.3

2022-11-113

OA

Cardiac Sarcoidosis: Current Approaches to Diagnosis and Management

CURRENT ALLERGY AND ASTHMA REPORTS

IF4.6

2022-10-293

PRE

Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence

JOURNAL OF RHEUMATOLOGY

IF3.4

2022-09-012

OA

Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms

LUPUS SCIENCE & MEDICINE

IF3.5

2022-08-0512

OAAI

Barriers to Taking Medications for Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers, and Clinic Staff

ARTHRITIS CARE & RESEARCH

IF3.3

2022-06-0112

OA

Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test

健康素养和算术与狼疮知识的关联以及狼疮知识评估测试的创建

JOURNAL OF RHEUMATOLOGY

IF3.4

2022-03-013

PRE

Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes

ARTHRITIS CARE & RESEARCH

IF3.3

2021-02-2526

PREAI

Racial Differences in Patient-provider Communication, Patient Self-efficacy, and Their Associations With Systemic Lupus Erythematosus-related Damage: A Cross-sectional Survey

JOURNAL OF RHEUMATOLOGY

IF3.4

2020-09-0114

OA

No association of fibromyalgia and seronegative rheumatoid arthritis-the need for uniform application of fibromyalgia criteria in research studies: comment on the article by Doss et al Reply

ARTHRITIS & RHEUMATOLOGY

IF10.9

2017-02-270

OAAI

Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia

ARTHRITIS & RHEUMATOLOGY

IF10.9

2017-01-2835

OAAI